On August 10, 2026, President Trump signed an Executive Order, Delivering Gold Standard Childhood Vaccine Recommendations for Americans ("Executive Order"), that establishes what the Administration calls “Gold Standard Childhood Vaccine Recommendations” and directs the Department of Health and Human Services ("HHS") to develop related policy proposals within 90 days. The Executive Order continues the Administration’s efforts to revise the childhood immunization schedule but does not immediately change coverage requirements for plans and issuers. As discussed in our previous posts, some of these prior efforts are the subject of pending litigation. In March 2026, a court stayed the revised childhood vaccine schedule and the appointments of the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices ("ACIP") members who voted on it, finding a substantial likelihood that the committee’s process did not comply with governing law.

The new Executive Order adopts an 11-disease framework similar to the one affected by the court’s stay. However, it does so through presidential action rather than the ACIP process. As such, it does not resolve the pending litigation concerning ACIP’s composition or procedures.

What Does the Executive Order Do?

Like the prior ACIP recommendations, the Executive Order places childhood and adolescent immunizations into three categories: (1) vaccines recommended for all children, (2) vaccines recommended for certain high-risk groups, and (3) vaccines recommended through shared clinical decision-making. Under this framework, vaccines for 11 diseases receive a universal recommendation, while others fall within the high-risk or shared-decision-making categories.

Within 90 days, the Executive Order directs HHS's Task Force on Safer Childhood Vaccines to deliver a plan to, among other things:

• Offer the MMR vaccine as three separate single-disease shots rather than a combination product, while preserving access to combination vaccines;
• Reassess the timing and sequencing of the federal childhood and adolescent immunization schedule; and
• Strengthen vaccine safety monitoring and transparency.

The Executive Order further directs federal agencies to advance these recommendations “to the fullest extent allowable by law” and encourages states to consider aligning school-entry vaccination requirements with the framework. It also directs the Departments of Justice, Education, and HHS to pursue legal action deemed meritorious against state laws viewed as conflicting with parental authority, religious liberty, disability accommodation, or equal protection obligations, including requirements concerning religious and medical exemptions.

Why This Matters for Plans and Issuers

The Executive Order states executive branch policy but does not itself revise the CDC immunization schedule adopted based on ACIP recommendations. Under the Affordable Care Act, non-grandfathered group health plans and issuers generally must cover ACIP-recommended immunizations without cost-sharing. Because the Executive Order does not independently change ACIP recommendations or the CDC-adopted schedule, current coverage requirements remain unchanged.

Providers remain concerned with the Administration’s policy direction on vaccines.

Relatedly, on August 12, 2026, HHS posted a solicitation seeking nominations for new members of the National Vaccine Advisory Committee, a federal panel that advises the agency on policies surrounding vaccine safety and research. The notice begins the process for selecting panel members who can serve for overlapping terms of up to four years. The committee advises the director of the National Vaccine Program, a role held by the assistant secretary for health.

In addition, on August 21, 2026, HHS announced a request for information seeking public input on the categories used in federal vaccine recommendations and the role of shared clinical decision-making to further advance the goals of the Executive Order.  HHS states that input received through the RFI will help HHS and the Task Force on Safer Childhood Vaccines evaluate whether the current recommendation framework adequately advances scientific rigor, informed choice, and public trust. The comment period is open through September 20, 2026. 

We continue to monitor developments, including the Task Force's forthcoming plans and any updates regarding the ACIP litigation. See our prior alerts on the ACIP/CDC vaccine changes here:

• Court Stays the Updated Childhood Vaccine Recommendations, Katie Amin, Lisa Campbell, Michelle Koltov
• CDC Adopts Part of ACIP’s Updated Recommendations for Hepatitis B Vaccine for Infants, Lisa Campbell, Michelle Koltov
• ACIP Updates its Recommendation for Hepatitis B Vaccine for Infants, Lisa Campbell, Michelle Koltov
• CDC Updates Immunization Schedule to Reflect ACIP's Recommendations | Groom Law Group
• ACIP Vaccine Meeting – Implications for Plans and Issuers | Groom Law Group